The individual behavior of a patient’s myeloproliferative neoplasm (MPN) will determine how the disease is monitored and ...

Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Metastatic Pancreatic Cancer.

Purinostat mesylate is under clinical development by Chengdu Zenitar Biomedical Technology and currently in Phase I for Unspecified B-Cell Lymphomas.

A patient with MPN urges others to ask questions about treatment options, which may also include inquiring about clinical ...

While in nursing school, a patient recognized potential signs of a blood disorder and advocated for further testing, leading ...

Advances in robotic-assisted surgery are redefining the approach to thyroid and parotid salivary gland conditions, offering solutions that prioritize precision, minimal invasiveness, and ...

To this end, advances in genomics that have illuminated new signaling pathways and biomarkers are leading to revised adrenal neoplasm taxonomies that offer new opportunities for disease stratification ...

Key Takeaways from the Pacemakers Market Report .In December 2024:- NCH Healthcare System, Inc. dba Naples Comprehensive Health and dba NCH- This is a prospective, randomized controlled (1:1) ...

Russia and other hostile states have become increasingly brazen in adopting “gray zone” attacks against Europe and the United States, leaving defense officials with a dilemma: How to respond ...

A Brazilian influencer whose staggering 32-stone weight loss made him the star of a reality TV show has died aged 37 after piling on the pounds again following the loss of his dad and brother ...

He will be sentenced on Jan. 10, shortly before his inauguration, but is unlikely to face jail time or other penalties. United Statescategory Even before US alcohol warning, younger Americans were ...

Christian converts in Kosovo, where the vast majority of people are Muslim, hope to revive a pre-Islamic past they see as a key to their European identity. By Andrew Higgins and Fatjona Mejdini ...